SOMATOPRIM

Pharmaceutical preparations containing a somatostatin analog for inhibition of growth hormone secretion, or for use in treatment of gastrointestinal and endocrine disorders, cancers, pancreatitis, disorders associated with angiogenesis, autoimmune diseases and inflammatory diseases, in humans and animals